Board of Directors & Board committees

Board committees

Audit committee

  • Maris Hartmanis, chairman
  • Hans Arwidsson
  • Christine Lind

Renumeration committee

  • Michael Wolff Jensen, ordförande
  • Gunnar Gårdemyr
  • Torbjörn Koivisto

Board of Directors

  • Michael Wolff Jensen

    Chairman

    Board member as well as chairman since 2013

    Born 1971

    Education: Master of Laws (LL.M.), University of Copenhagen

    Other current activities: Chairman of the Board in Ascendis Pharma A/S and Chairman of the Board as well as owner of MWJ Partners ApS

    Other board assignments (the recent 5 years): Eurocines Vaccines AB and VANX ApS.

    Holdings: 35,864 shares and 25,000 warrants through MWJ Partners ApS

    Independent in relation to both the larger shareholders and the company.

  • Hans Arwidsson

    Board member since 2006

    Born 1958

    Education: Ph.D. in Pharmaceutical Science and Pharmacist’s Degree, University of Uppsala as well as Master of Business Administration, Executive MBA, Stockholm School of Economics

    Other current activities: Board member of Healthy Bizniz Europe AB, Eurocince Securities AB and Nanexa AB, CEO of Eurocine Vaccines AB

    Holdings: None

    Independent in relation to both the larger shareholders and the company.

  • Maris Hartmanis

    Board member since 2015

    Born 1953

    Education: Dr. of Technology and Associate Professor, Royal Institute of Technology

    Other current activities: CEO and Chairman of the Board in Hartmanis & Partners AB as well as board member in Xbrane Biopharma AB, Applied Photophysics Ltd and BioLamina

    Holdings: 26,494 shares

    Independent in relation to both the larger shareholders and the company.

  • Carl-Johan Spak

    Board member since 2015

    Born 1956

    Education: Dr. of Odontology, Degree in Dentistry, Karolinska Institute

    Other current activities: Chairman of the Board in Recipharm OT Chemistry AB, Recipharm Pharmacaeutical Development AB, board member of Pharmanest AB, Symcel Sverige AB, Cobra Biologics Holding AB, Empros Pharma AB, Inject, Atrogi AB, Pharma Sweden AB, Prokarium Ltd., Synthonics Inc, Kahr Medical Ltd, member of board and CEO of Recipharm Venture Fund AB and RPH Pharmaceuticals AB.

    Holdings: None

    Independent in relation to both the larger shareholders and the company.

  • Torbjörn Koivisto

    Board member since 2017

    Born 1969

    Education: Master of Laws (LL.M.), University of Uppsala

    Other current activities: Board member of Moberg Pharma AB (publ), Hemcheck Sweden AB, Cinclus Pharma Holding AB, KIBACQ AB and IARU Institutet för Affärsjuridisk Rådgivning I Uppsala AB, bolagsman in KOL Arts & Craft Handelsbolag as well as deputy (styrelsesuppleant) of RJC Roger Johansson Consulting AB

    Holdings: 4,000 shares via company (IARU)
    Independent in relation to both the larger shareholders and the company.

  • Christine Lind

    Board member since 2019

    Born 1974

    Education: Bachelors in Science in Finance and information Systems, New York University, Masters in Business Administration in Finance and Management, Columbia Business School

    Other current activities: Chairman and CEO of Lind Growth Strategy AB, Strategic Advisor of BioArctic AB and board member of Shinka Life Sciences AB

    Other board assignments (the recent 5 years): VP Business Development of LifeCell Corporation, EVP Strategic Business Development of Medivir AB and CEO of Medivir AB
    Holdings: None
    Independent in relation to both the larger shareholders and the company

  • Gunnar Gårdemyr

    Board member since 2019

    Born 1959

    Education: BSc Economy, University of Lund

    Other current activities: Board member of Rhovac AB, CBO Follicum AB

    Other board assignments (the recent 5 years): VD Targovax AS, Norge
    Holdings: 400 shares
    Independent in relation to both the larger shareholders and the company